Back to Search
Start Over
High-risk medication use for Clostridium difficile infection among hospitalized patients with cancer
- Source :
- American Journal of Infection Control. 47:217-219
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
-
Abstract
- Patients with cancer are vulnerable to Clostridium difficile infection (CDI); hospitals with larger oncology populations may have worse CDI performance. Among 71 academic hospitals studied, there were significant differences in oncology patient-days per 1,000 admissions across CDI standardized infection ratio categories of better, no different, and worse; worse hospitals had the greatest number of patient-days. Oncology patients' most commonly used high-risk CDI medications were quinolones, third- and fourth-generation cephalosporins, and proton pump inhibitors.
- Subjects :
- Adult
Male
medicine.medical_specialty
Adolescent
Drug-Related Side Effects and Adverse Reactions
genetic structures
Risk medication
Epidemiology
Hospitalized patients
Young Adult
03 medical and health sciences
0302 clinical medicine
Drug Therapy
Neoplasms
Internal medicine
medicine
Humans
030212 general & internal medicine
Aged
Aged, 80 and over
Academic Medical Centers
Inpatients
0303 health sciences
030306 microbiology
business.industry
Incidence
Health Policy
Public Health, Environmental and Occupational Health
Cancer
Middle Aged
Clostridium difficile
medicine.disease
Cross-Sectional Studies
Infectious Diseases
Clostridium Infections
Female
Oncology patients
business
Subjects
Details
- ISSN :
- 01966553
- Volume :
- 47
- Database :
- OpenAIRE
- Journal :
- American Journal of Infection Control
- Accession number :
- edsair.doi.dedup.....dfe5439af6a891933c927334ca588c94